Covered recipient · General Payments record
DON MANARANG
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,870.87
- Reported across 99 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $550.33 | 32 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $200.89 | 16 |
| Indivior Inc. | $78.71 | 3 |
| Lilly USA, LLC | $65.60 | 3 |
| Exact Sciences Corporation | $34.02 | 2 |
| Acerta Pharma LLC | $29.55 | 1 |
| SANOFI-AVENTIS U.S. LLC | $28.96 | 1 |
| Novo Nordisk AS | $21.67 | 1 |
| Axsome Therapeutics, Inc. | $20.69 | 1 |
| Janssen Pharmaceuticals, Inc | $20.34 | 1 |
| Otsuka America Pharmaceutical, Inc. | $19.80 | 1 |
| Nevro Corp. | $16.71 | 1 |
| Phathom Pharmaceuticals, Inc. | $13.39 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (32)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.90 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104951559 | CMS |
| ABBVIE INC. | $19.11 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104951563 | CMS |
| ABBVIE INC. | $8.51 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104951567 | CMS |
| ABBVIE INC. | $19.23 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104951571 | CMS |
| ABBVIE INC. | $25.83 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104951575 | CMS |
| ABBVIE INC. | $5.41 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104951579 | CMS |
| ABBVIE INC. | $19.99 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104951583 | CMS |
| ABBVIE INC. | $19.85 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104951587 | CMS |
| ABBVIE INC. | $14.86 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104951591 | CMS |
| ABBVIE INC. | $7.66 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104951595 | CMS |
| ABBVIE INC. | $3.68 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104951599 | CMS |
| ABBVIE INC. | $5.46 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104951603 | CMS |
| ABBVIE INC. | $5.11 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104951606 | CMS |
| ABBVIE INC. | $4.28 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104951610 | CMS |
| ABBVIE INC. | $5.47 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104951615 | CMS |
| ABBVIE INC. | $17.54 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104951618 | CMS |
| AstraZeneca Pharmaceuticals LP | $29.55 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105890520 | CMS |
| Axsome Therapeutics, Inc. | $20.69 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148277438 | CMS |
| Exact Sciences Corporation | $15.79 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114770394 | CMS |
| Exact Sciences Corporation | $18.23 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114770400 | CMS |
| Indivior Inc. | $27.24 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144532823 | CMS |
| Indivior Inc. | $29.78 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144532825 | CMS |
| Indivior Inc. | $21.69 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144532827 | CMS |
| Janssen Pharmaceuticals, Inc | $20.34 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078012872 | CMS |
| Lilly USA, LLC | $15.24 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136172176 | CMS |
| Lilly USA, LLC | $24.61 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136172174 | CMS |
| Lilly USA, LLC | $25.75 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136148082 | CMS |
| Nevro Corp. | $16.71 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130763753 | CMS |
| Novo Nordisk Inc | $21.67 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097306185 | CMS |
| Otsuka America Pharmaceutical, Inc. | $19.80 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118935068 | CMS |
| Phathom Pharmaceuticals, Inc. | $13.39 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151092295 | CMS |
| SANOFI-AVENTIS U.S. LLC | $28.96 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139628046 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.